Search
Publication

Darifenacin: a promising chitinase 3-like 1 inhibitor to tackle drug resistance in pancreatic ductal adenocarcinoma

READ ON ORCID
Authors
Sousa S.M., Branco H., Avan A., Palmeira A., Morelli L., Santos L.L., Giovannetti E., Vasconcelos M.H., Xavier C.P.R.
Date
2024-01-01
Source
Cancer Chemotherapy and Pharmacology
DOI
https://doi.org/10.1007/s00280-024-04712-1
EID
2-s2.0-85203014422